• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环丙沙星增强癌细胞对 ABCB1 底物的化疗敏感性。

Ciprofloxacin Enhances the Chemosensitivity of Cancer Cells to ABCB1 Substrates.

机构信息

Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA.

Department of Histology and Embryology, Weifang Medical University, Weifang 261053, China.

出版信息

Int J Mol Sci. 2019 Jan 11;20(2):268. doi: 10.3390/ijms20020268.

DOI:10.3390/ijms20020268
PMID:30641875
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6358874/
Abstract

ABCB1 is one of the major drug efflux transporters that is known to cause multidrug resistance (MDR) in cancer patients receiving chemotherapy for the treatment of solid tumors and hematological malignancies. Inhibition of ABCB1 efflux function is important for maintaining the intracellular concentration of chemotherapeutic drugs. Here, we evaluated ciprofloxacin for its ability to reverse MDR caused by the overexpression of ABCB1. Cytotoxicity of ciprofloxacin was determined by the MTT assay. The chemosensitizing effects of ciprofloxacin were determined in combination with ABCB1 substrates. The intracellular accumulation and efflux of ABCB1 substrates was measured by a scintillation counter, and protein expression was determined by the Western blotting. Vanadate-sensitive ATPase assay was performed to determine the effect of ciprofloxacin on the ATPase activity of ABCB1, and docking analysis was done to determine the interaction of ciprofloxacin with ABCB1. Ciprofloxacin significantly potentiated the cytotoxic effects of ABCB1 substrates in ABCB1-overexpressing cells. Furthermore, ciprofloxacin increased the intracellular accumulation and decreased the efflux of [³H]-paclitaxel without altering the expression of ABCB1. Ciprofloxacin stimulated the ATPase activity of ABCB1 in a concentration-dependent manner. Our findings showed that ciprofloxacin potently inhibits the ABCB1 efflux function and it has potential to be developed as a combination anticancer therapy.

摘要

ABCB1 是一种主要的药物外排转运蛋白,已知它会导致接受化疗治疗实体瘤和血液恶性肿瘤的癌症患者产生多药耐药性(MDR)。抑制 ABCB1 的外排功能对于维持化疗药物的细胞内浓度很重要。在这里,我们评估了环丙沙星逆转 ABCB1 过表达引起的 MDR 的能力。通过 MTT 测定法测定环丙沙星的细胞毒性。通过与 ABCB1 底物联合测定环丙沙星的化学增敏作用。通过闪烁计数器测量 ABCB1 底物的细胞内积累和外排,通过 Western 印迹测定蛋白表达。通过钒酸盐敏感的 ATP 酶测定法测定环丙沙星对 ABCB1 的 ATP 酶活性的影响,并进行对接分析以确定环丙沙星与 ABCB1 的相互作用。环丙沙星在 ABCB1 过表达细胞中显著增强了 ABCB1 底物的细胞毒性作用。此外,环丙沙星增加了[³H]-紫杉醇的细胞内积累并减少了其外排,而不改变 ABCB1 的表达。环丙沙星以浓度依赖的方式刺激 ABCB1 的 ATP 酶活性。我们的研究结果表明,环丙沙星强烈抑制 ABCB1 的外排功能,有潜力开发为联合抗癌疗法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1428/6358874/cec0ebf7bd69/ijms-20-00268-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1428/6358874/de49db3357d1/ijms-20-00268-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1428/6358874/c73c8dc725fe/ijms-20-00268-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1428/6358874/a271970bbbdf/ijms-20-00268-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1428/6358874/4090a54f4693/ijms-20-00268-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1428/6358874/05aa84094a5d/ijms-20-00268-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1428/6358874/cec0ebf7bd69/ijms-20-00268-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1428/6358874/de49db3357d1/ijms-20-00268-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1428/6358874/c73c8dc725fe/ijms-20-00268-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1428/6358874/a271970bbbdf/ijms-20-00268-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1428/6358874/4090a54f4693/ijms-20-00268-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1428/6358874/05aa84094a5d/ijms-20-00268-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1428/6358874/cec0ebf7bd69/ijms-20-00268-g006.jpg

相似文献

1
Ciprofloxacin Enhances the Chemosensitivity of Cancer Cells to ABCB1 Substrates.环丙沙星增强癌细胞对 ABCB1 底物的化疗敏感性。
Int J Mol Sci. 2019 Jan 11;20(2):268. doi: 10.3390/ijms20020268.
2
Voruciclib, a Potent CDK4/6 Inhibitor, Antagonizes ABCB1 and ABCG2-Mediated Multi-Drug Resistance in Cancer Cells.沃鲁西利布,一种强效的细胞周期蛋白依赖性激酶4/6(CDK4/6)抑制剂,可拮抗ABCB1和ABCG2介导的癌细胞多药耐药性。
Cell Physiol Biochem. 2018;45(4):1515-1528. doi: 10.1159/000487578. Epub 2018 Feb 19.
3
Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression.汉防己甲素通过与抗癌药物竞争并下调 ABCB1 表达逆转癌细胞的多药耐药性。
Molecules. 2019 Nov 30;24(23):4383. doi: 10.3390/molecules24234383.
4
The FLT3 inhibitor midostaurin selectively resensitizes ABCB1-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.FLT3 抑制剂 midostaurin 选择性地使 ABCB1 过表达的多药耐药癌细胞重新对常规化疗药物敏感。
Cancer Lett. 2019 Mar 31;445:34-44. doi: 10.1016/j.canlet.2019.01.001. Epub 2019 Jan 11.
5
PD173074, a selective FGFR inhibitor, reverses ABCB1-mediated drug resistance in cancer cells.PD173074,一种选择性 FGFR 抑制剂,可逆转 ABCB1 介导的癌细胞耐药性。
Cancer Chemother Pharmacol. 2013 Jul;72(1):189-99. doi: 10.1007/s00280-013-2184-z. Epub 2013 May 15.
6
Tangeretin, a citrus pentamethoxyflavone, antagonizes ABCB1-mediated multidrug resistance by inhibiting its transport function.橘红素,一种源自柑橘的五甲氧基黄酮,通过抑制 ABCB1 的转运功能来拮抗 ABCB1 介导的多药耐药性。
Pharmacol Res. 2016 Aug;110:193-204. doi: 10.1016/j.phrs.2016.04.003. Epub 2016 Apr 4.
7
Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo.免疫肿瘤药物 IPI-549 是一种调节 P-糖蛋白(P-gp,MDR1,ABCB1)介导的癌症多药耐药(MDR)的调节剂:体外和体内。
Cancer Lett. 2019 Feb 1;442:91-103. doi: 10.1016/j.canlet.2018.10.020. Epub 2018 Nov 1.
8
C-phycocyanin to overcome the multidrug resistance phenotype in human erythroleukemias with or without interaction with ABC transporters.藻蓝蛋白克服人红白血病多药耐药表型,无论有无 ABC 转运蛋白的相互作用。
Biomed Pharmacother. 2018 Oct;106:532-542. doi: 10.1016/j.biopha.2018.06.145. Epub 2018 Jul 11.
9
Acerinol, a cyclolanstane triterpenoid from Cimicifuga acerina, reverses ABCB1-mediated multidrug resistance in HepG2/ADM and MCF-7/ADR cells.升麻醇,一种来自 Acerina 升麻的环羊毛甾烷三萜类化合物,可逆转 HepG2/ADM 和 MCF-7/ADR 细胞中 ABCB1 介导的多药耐药性。
Eur J Pharmacol. 2014 Jun 15;733:34-44. doi: 10.1016/j.ejphar.2014.03.043. Epub 2014 Apr 4.
10
Overexpression of ABCB1 Transporter Confers Resistance to mTOR Inhibitor WYE-354 in Cancer Cells.ABCB1 转运蛋白的过表达赋予癌细胞对 mTOR 抑制剂 WYE-354 的耐药性。
Int J Mol Sci. 2020 Feb 19;21(4):1387. doi: 10.3390/ijms21041387.

引用本文的文献

1
Repurposing fluoroquinolones as cancer chemosensitizers: a way to overcome cancer therapeutic bottleneck.将氟喹诺酮类药物重新用作癌症化疗增敏剂:一种克服癌症治疗瓶颈的方法。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Aug 11. doi: 10.1007/s00210-025-04508-x.
2
Ciprofloxacin Exerts Anti-Tumor Effects In Vivo Through cGAS-STING Activation and Modulates Tumor Microenvironment.环丙沙星通过激活cGAS-STING在体内发挥抗肿瘤作用并调节肿瘤微环境。
Cells. 2025 Jul 2;14(13):1010. doi: 10.3390/cells14131010.
3
Cuproptosis-related genes and agents: implications in tumor drug resistance and future perspectives.

本文引用的文献

1
Modulating ROS to overcome multidrug resistance in cancer.调节活性氧以克服癌症的多药耐药性。
Drug Resist Updat. 2018 Nov;41:1-25. doi: 10.1016/j.drup.2018.11.001. Epub 2018 Nov 14.
2
Ulixertinib (BVD-523) antagonizes ABCB1- and ABCG2-mediated chemotherapeutic drug resistance.乌利替尼(BVD-523)拮抗 ABCB1 和 ABCG2 介导的化疗药物耐药性。
Biochem Pharmacol. 2018 Dec;158:274-285. doi: 10.1016/j.bcp.2018.10.028. Epub 2018 Oct 26.
3
VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters.
铜死亡相关基因与药物:对肿瘤耐药性的影响及未来展望
Front Pharmacol. 2025 May 8;16:1559236. doi: 10.3389/fphar.2025.1559236. eCollection 2025.
4
The Gut Microbiome and Its Multifaceted Role in Cancer Metabolism, Initiation, and Progression: Insights and Therapeutic Implications.肠道微生物群及其在癌症代谢、发生和进展中的多方面作用:见解与治疗意义
Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251331960. doi: 10.1177/15330338251331960. Epub 2025 Apr 10.
5
Synergistic Potential of Antibiotics with Cancer Treatments.抗生素与癌症治疗的协同潜力。
Cancers (Basel). 2024 Dec 28;17(1):59. doi: 10.3390/cancers17010059.
6
Preclinical studies of the falnidamol as a highly potent and specific active ABCB1 transporter inhibitor.法尼达莫尔作为一种高效且特异性的活性ABCB1转运蛋白抑制剂的临床前研究。
BMC Cancer. 2025 Jan 7;25(1):24. doi: 10.1186/s12885-024-13371-7.
7
Noninvasive Ultra Low Intensity Light Photodynamic Treatment of Glioblastoma with Drug Augmentation: LoGlo PDT Regimen.药物增强的胶质母细胞瘤非侵入性超低强度光动力治疗:低强度光动力疗法方案
Brain Sci. 2024 Nov 21;14(12):1164. doi: 10.3390/brainsci14121164.
8
Synthesis of Novel Artemisinin, Ciprofloxacin, and Norfloxacin Hybrids with Potent Antiplasmodial Activity.具有强效抗疟活性的新型青蒿素、环丙沙星和诺氟沙星杂合物的合成。
Antibiotics (Basel). 2024 Feb 1;13(2):142. doi: 10.3390/antibiotics13020142.
9
N-Acylated Ciprofloxacin Derivatives: Synthesis and In Vitro Biological Evaluation as Antibacterial and Anticancer Agents.N-酰化环丙沙星衍生物:作为抗菌和抗癌药物的合成及体外生物学评价
ACS Omega. 2023 May 18;8(21):18663-18684. doi: 10.1021/acsomega.3c00554. eCollection 2023 May 30.
10
Antiproliferative Activity of Antibiotics through DNA Binding Mechanism: Evaluation and Molecular Docking Studies.抗生素通过 DNA 结合机制的抗增殖活性:评估和分子对接研究。
Int J Mol Sci. 2023 Jan 29;24(3):2563. doi: 10.3390/ijms24032563.
VS-4718通过抑制ABC转运蛋白的外排功能来拮抗ABCB1和ABCG2过表达癌细胞中的多药耐药性。
Front Pharmacol. 2018 Oct 30;9:1236. doi: 10.3389/fphar.2018.01236. eCollection 2018.
4
Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo.免疫肿瘤药物 IPI-549 是一种调节 P-糖蛋白(P-gp,MDR1,ABCB1)介导的癌症多药耐药(MDR)的调节剂:体外和体内。
Cancer Lett. 2019 Feb 1;442:91-103. doi: 10.1016/j.canlet.2018.10.020. Epub 2018 Nov 1.
5
Ciprofloxacin: from infection therapy to molecular imaging.环丙沙星:从感染治疗到分子成像
Mol Biol Rep. 2018 Oct;45(5):1457-1468. doi: 10.1007/s11033-018-4220-x. Epub 2018 Jul 4.
6
Synthesis and biological evaluation of 2,5-disubstituted furan derivatives as P-glycoprotein inhibitors for Doxorubicin resistance in MCF-7/ADR cell.合成及生物评价 2,5-二取代呋喃衍生物作为多柔比星耐药 MCF-7/ADR 细胞中的 P-糖蛋白抑制剂
Eur J Med Chem. 2018 May 10;151:546-556. doi: 10.1016/j.ejmech.2018.04.012. Epub 2018 Apr 5.
7
Ciprofloxacin triggers the apoptosis of human triple-negative breast cancer MDA-MB-231 cells via the p53/Bax/Bcl-2 signaling pathway.环丙沙星通过p53/Bax/Bcl-2信号通路诱导人三阴性乳腺癌MDA-MB-231细胞凋亡。
Int J Oncol. 2018 May;52(5):1727-1737. doi: 10.3892/ijo.2018.4310. Epub 2018 Mar 8.
8
Epidermal growth factor receptor (EGFR) inhibitor PD153035 reverses ABCG2-mediated multidrug resistance in non-small cell lung cancer: In vitro and in vivo.表皮生长因子受体(EGFR)抑制剂 PD153035 逆转非小细胞肺癌中 ABCG2 介导的多药耐药:体外和体内。
Cancer Lett. 2018 Jun 28;424:19-29. doi: 10.1016/j.canlet.2018.02.040. Epub 2018 Mar 5.
9
Voruciclib, a Potent CDK4/6 Inhibitor, Antagonizes ABCB1 and ABCG2-Mediated Multi-Drug Resistance in Cancer Cells.沃鲁西利布,一种强效的细胞周期蛋白依赖性激酶4/6(CDK4/6)抑制剂,可拮抗ABCB1和ABCG2介导的癌细胞多药耐药性。
Cell Physiol Biochem. 2018;45(4):1515-1528. doi: 10.1159/000487578. Epub 2018 Feb 19.
10
Quercetin enhances chemotherapeutic effect of doxorubicin against human breast cancer cells while reducing toxic side effects of it.槲皮素增强阿霉素对人乳腺癌细胞的化疗效果,同时降低其毒副作用。
Biomed Pharmacother. 2018 Apr;100:441-447. doi: 10.1016/j.biopha.2018.02.055. Epub 2018 Feb 22.